Background This study seeks to identify factors associated with periprocedural complications of carotid artery stenting (CAS) to best understand CAS complication rates and optimize patient outcomes. Periprocedural complications include major adverse cardiovascular and cerebrovascular events (MACCE) that include myocardial infarction (MI), stroke, or death. Methods We retrospectively analyzed 181 patients from Northern Michigan who underwent CAS. Rates of stroke, MI, and death occurring within 30 days post-procedure were examined. Associations of open vs. closed cell stent type, demographics, comorbidities, and symptomatic carotid stenosis were compared to determine significance. All patients had three NIH Stroke Scale (NIHSS) exams: at baseline, 24 h post-procedure, and at the one-month visit. Cardiac enzymes were measured twice in all patients, within 24 h post-procedure. All patients were treated with dual anti-platelet therapy for at least 6 months post-procedure. Results Three patients (1.66%) experienced a major complication within one-month post-procedure. These complications included one MI (0.55%), one stroke (0.55%), and one death (0.55%). The following variable factors were not associated with the occurrence of MACCE complications within 30 days post-procedure: stent design (open vs. closed cell) (p = 1.000), age ≥80 (p = 0.559), smoking history (p = 0.569), hypertension (p = 1.000), diabetes (p = 1.000), and symptomatic carotid stenosis (p = 0.254). Conclusions Age of 80 years old or above, symptomatic carotid stenosis, open-cell stent design, and history of diabetes, smoking, or hypertension were not found to have an association with MACCE within 1 month after CAS. Future studies using a greater sample size will be beneficial to better assess periprocedural complication risks of CAS, while also considering the effect of operator experience and technological advancements on decreasing periprocedural complication rates.
- Carotid artery stenting
- Periprocedural complications